Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 52 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9453028

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  2. US 9447047

    Inhibitors of protein phosphatase-1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  3. US 9446139

    Polymer-based compositions and conjugates of HIV entry inhibitors

    Nektar Therapeutics · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  4. US 9428457

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  5. US 9422245

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  6. US 9422271

    Pyrimidine compounds as tuberculosis inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  7. US 9422340

    Macrocyclic compounds useful as inhibitors of histone deacetylases

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  8. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  9. US 9416165

    Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors

    The Regents of the University of California · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  10. US 9408813

    Small-molecule inhibitors of dengue virus proteases

    The Board of Regents of the University of Texas System · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  11. US 9408829

    Inhibitors of CD40-TRAF6 interaction

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  12. US 9403819

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  13. US 9403856

    Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  14. US 9394316

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  15. US 9394303

    Small molecule inhibitors of MCL-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  16. US 9394302

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  17. US 9393245

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  18. US 9388189

    Pyrrolotriazinone derivatives as PI3K inhibitors

    Almirall, S.A. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  19. US 9388145

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  20. US 9387205

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  21. US 9388408

    Oligonucleotide-based inhibitors comprising locked nucleic acid motif

    MIRAGEN THERAPEUTICS, INC. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  22. US 9382213

    Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  23. US 9382256

    Formulation of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  24. US 9375402

    Oral formulations of kinase inhibitors

    VERASTEM, INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted